This is an interview with the French cell and molecular biologist Daniel Louvard who was Head of a research group at EMBL Heidelberg from 1978 until 1982. In this interview, Daniel Louvard explains why he decided to work at EMBL as a postdoc and how he developed his research on epithelial functions, on membrane trafficking and on producing monoclonal antibodies at that time. Furthermore, Daniel Louvard describes the working environment at EMBL, how he later became Head of Unit at the Pasteur Institute and his scientific work after his time at EMBL, especially his foundation of the ATIP-avenir program.
This is an interview with Nadia Rosenthal who has been the Head of Mouse Biology Unit at EMBL Monterotondo (Rome) and Senior Scientist at the Developmental Biology Unit at EMBL Heidelberg from 2001 until 2011. In this interview, Nadia Rosenthal describes how she came to the position as Head of the Mouse Biology Unit at EMBL Rome and how she was involved in establishing the Mouse Biology program there. The working conditions at the EMBL in Rome are part of this interview as well as Nadia Rosenthal's contribution in relation to making Australia the first associate member of EMBL.
This is an interview with Alan Sawyer who started to work as a technical assistant at EMBL Heidelberg in 1990 in Thomas Kreis' and Eric Karsenti's group. In this interview, Alan Sawyer describes how he started working in the UK before coming to EMBL, how he developed his methods of producing antibodies at EMBL Heidelberg and how he came to work on microarrays at EMBL after 2001 as well as on one of the Core Facilities after 2008. Furthermore, this interview contains some anecdotes of Alan Sawyer's life in Heidelberg and how he perceives the process of professionalization of EMBL over time.
This is an interview with the evolutionary developmental biologist and Nobel Prize-winner Eric Wieschaus who was a group leader at EMBL Heidelberg between 1978 and 1981. In this interview, Eric Wieschaus describes how he became interested in flies an how he and Christiane Nüsslein-Vollhard came from working with Walter Gehring to starting at EMBL. Furthermore, Eric Wieschaus gives an insight of his daily work at EMBL, especially concerning mutagenesis and later zygotically active lethals screening. He also describes the cooperation with the EMBL facilities and he gives a special insight into his impressions of EMBLs first DG, Sir John Kendrew.
This is an interview with the geneticist and cell biologist Edith Heard who has become EMBLs fifth DG in January 2019 and who is also head of department at the Curie Institute and professor at the College de France. In this interview, Edith Heard describes the development of her scientific career and of her interest in the genetic control of X-chromosome inactivation and its epigenetics. She also talks about how she came in touch with EMBL through Daniel Louvard. Furthermore, Edith Heard gives an insight of how she witnessed her election as DG and what ideas she has for EMBLs future in relation to research in molecular biology, but also in relation to the different EMBL sites and the administration.
This is an interview with the 2001 Nobel Prize Winner Tim Hunt who became member of EMBO in 1978. In this interview, Tim Hunt gives an insight of his career as a biochemist before joining EMBO, especially his work on S 35 Methionine. He also describes his connections with other scientists at EMBL since 1978. Furthermore, Tim Hunt reflects the meaning of the Data Library and the role of EMBO and the EMBO journal in general.
This is an interview with the molecular biologist Joan Steitz. In this interview, Joan Steitz describes the stations of her scientific career in connection to her work on RNA phages. She also explains how she came in touch with EMBL through the SAC meetings and her scientific interest into snRNPs. Furthermore, Joan Steitz gives an insight into her impressions of the first three DGs and of female scientists at EMBL.
In this interview, Jacques Dubochet who won the 2017 Nobel Prize in Chemistry descibes his work as a group leader at EMBL Heidelberg. This interview contains Dubochet's description of the research environment in which he developed cryo-EM sample preparation and vitrification. Furthermore, the interview contains some information about Dubochet's early life and career as well as his assessment of the current state of science, especially with regard to genetic editing.
This is an interview with Eero Vuorio who has been a council delegate and Chairman of the EMBL council. In this interview, Eero Vuorio describes his career from working on molecular cloning of RNA and DNA to administration. He gives an insight of the work of the EMBL council, especially in terms of raising financial resources and in terms of the procedure of electing a new DG for EMBL. Furthermore, Eero Vuorio analyses the development of the administration of EMBL, also in connection to the different EMBL sites.
This is an interview with the 2019 John Kendrew Award winner Tanmay Bharat who was a PhD student at EMBL Heidelberg from 2008 until 2012. In this interview, Tanmay Bharat describes how he started working on pathogenic viruses in John Brigg's group. He also explains why he started working on bacterial antibodies using cryo-electron tomography. Furthermore, he reflects the upcoming of personalised medicine nowadays in this interview.